These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4594836)

  • 1. [Protective role of type-specific Shigella flexneri 2A antigen in interaction with immune sera in passive protection experiments on a "lung" model].
    Blinova NI
    Vestn Akad Med Nauk SSSR; 1973; 28(11):44-7. PubMed ID: 4594836
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a.
    Pore D; Chowdhury P; Mahata N; Pal A; Yamasaki S; Mahalanabis D; Chakrabarti MK
    Vaccine; 2009 Sep; 27(42):5855-64. PubMed ID: 19660587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioprotective properties of Shigella antigens].
    Gorbunova ES; Mal'tsev VN; Tiurin EA
    Radiobiologiia; 1981; 21(4):591-4. PubMed ID: 7029609
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reaction of the hematopoietic system in mice to the administration of virulent and avirulent strains of Shigella flexneri 2A].
    Nikolaeva TN; Sanin AV; Belaia IuA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1987; (6):17-22. PubMed ID: 3304434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Shigella flexneri 2a 34 kDa outer membrane protein in induction of protective immune response.
    Mukhopadhaya A; Mahalanabis D; Chakrabarti MK
    Vaccine; 2006 Aug; 24(33-34):6028-36. PubMed ID: 16765491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.
    Fennelly GJ; Khan SA; Abadi MA; Wild TF; Bloom BR
    J Immunol; 1999 Feb; 162(3):1603-10. PubMed ID: 9973419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
    Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
    J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproduction of phage conversion of the somatic antigen of Shigella flexneri on hybrids of Escherichia coli.
    Petrovskaya VG; Nevskaya NA; Khomenko NA
    Sov Genet; 1974 Sep; 8(9):1163-6. PubMed ID: 4139766
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective properties of peptidoglycan associated protein of Shigella flexneri.
    Mulczyk M; Adamus G; Witkowska D
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):631-5. PubMed ID: 6398687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recipient properties of Shigella newcastle after crossing with E. coli K-12 and Sh. flexneri 2c Hfr strains and the antigenic structure of the hybrids].
    Makletsova IuI
    Vestn Akad Med Nauk SSSR; 1973; 28(11):47-50. PubMed ID: 4594837
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysogenic conversion in the Shigella flexneri group.
    Kétyi I; Vertényi A; Financsek I
    Acta Microbiol Acad Sci Hung; 1971; 18(1):47-54. PubMed ID: 4947098
    [No Abstract]   [Full Text] [Related]  

  • 15. Serologic analysis of the lac + hybrid of Escherichia coli K-12 HFRC and variant Y of Shigella flexneri.
    Kolodynski J
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):743-8. PubMed ID: 4946992
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obtaining dysentery and salmonellosis diagnostica for the coagglutination reaction in lyophilized form and the elaboration of a rapid system].
    Belaia IuA; Belaia OF
    Lab Delo; 1982; (8):486-8. PubMed ID: 6182376
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of the immune response with antigen specific IgM antibody: a dual role.
    Wason WM
    J Immunol; 1973 May; 110(5):1245-52. PubMed ID: 4633296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Shigella interaction with immune enterocytes].
    Polotskiĭ IuE; Seliverstova VG; Rukhamina ML; Krasnoproshina LI
    Arkh Patol; 1980; 42(12):39-46. PubMed ID: 7011272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.